A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM)

Clinical trial NCT02092922 · COMPLETED

Trial details

NCT number: NCT02092922
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Multiple Myeloma

Start date: 2014-05-01
Primary completion: 2016-07-01
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.